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Abstract
Background:  In recent years attention has focused on malignant prostatic lesions due to the perceived high
incidence of prostatic carcinoma in different geographical areas worldwide.
Unfortunately, African American race/ethnicity is one of the three primary non-modifiable risk factors
confirmed for prostate cancer.
Objective:  To analyze the pattern of distribution of prostate cancer among men in Zaria, Northern Nigeria.
Patients and  methods: This is a 10-year retrospective histopathological analysis of all prostate cancer cases
diagnosed between January 1991 and December 2000 in the Department of Pathology, Ahmadu Bello
University Teaching Hospital (A.B.U.T.H), Zaria, Nigeria. Haematoxylin & Eosin (H&E) stained histol-
ogy slides were retrieved and studied. The patients’ bio-data were retrieved from the patient case files
and departmental records. After histological assessment, the tumours were classified according to WHO
recommendation. Histological grading and staging of adenocarcinoma was done using the Gleason Score.
Results: Between January 1991 and December 2000, a total of 151 cases of prostate cancer were seen,
constituting 4.1% of all malignancies and 10.1% of male malignancies seen during this period. The diagnosis
was based on histopathological analysis of specimens obtained from Trucut needle biopsies and open
prostatectomies. The patients’ age ranged from 30 to 79 years with a mean age of 64.5 years. The peak
age at diagnosis was in the seventh decade, while two relatively young patients were found to have prostate
cancer at the age of 30 and 32, respectively. All the tumours were adenocarcinomas, 51.6% were poorly
and 58.4% moderately differentiated.
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Conclusion:  Prostate cancer is the most common cancer among men in Zaria, Northern Nigeria. Most of
the patients presented late. The peak age at diagnosis in this review was the seventh decade and two patients
aged 30 and 32 years were found to have prostate cancer.
© 2015 Pan African Urological Surgeons’ Association. Production and hosting by Elsevier B.V. All rights reserved.
Introduction
The incidence of prostate cancer has tripled during the past decade,
chiefly because of the widespread use of serum prostate-specific
antigen (PSA) testing, digital rectal examination (DRE) and tran-
srectal ultrasound. Needle biopsy of the prostate plays a central role
in the morphologic evaluation of prostate cancer [1]. The increase
in the detection of prostate cancer has induced a sharp increase in
the number of radical prostatectomies [2].
Prostate cancer is the most common non-cutaneous malignancy in
men and remains a leading cause of cancer-related deaths in the
United States [3]. The incidence and mortality due to prostate cancer
are high in the United States and Western Europe, with the highest
rates among African-Americans in the United States and lower rates
among the people of Asia [4].
Earlier studies on prostate cancer among African and Asian popu-
lations suggested that it was a rare disease [5–8]. However, there
has been a steady increase in the number of cases due to increased
men’s health publicity, a raised awareness of PSA testing, health
education and new medical treatment [9–11].
Although the aetiology of prostate cancer remains unknown, the
most consistent risk factors are advanced age and racial/ethnic
factors [12]. While genetic factors play a significant role in the devel-
opment of this disease, reports documenting an increased risk of
prostate cancer in Asians who immigrated to the United States from
China and Japan, where the prevalence of the disease is low, strongly
implicate the impact of environmental exposure [3,13]. Numerous
epidemiological studies of prostate cancer have identified an asso-
ciation between the consumption of particular dietary constituents,
such as red and/or charred meat, and prostate cancer incidence and
mortality [14–16].
Subjects  and  methods
This is a 10-year retrospective histopathological analysis of
all prostate cancer cases diagnosed between January 1991 and
December 2000 in the Department of Pathology, Ahmadu Bello
University Teaching Hospital (A.B.U.T.H), Zaria, Nigeria. Haema-
toxylin & Eosin (H&E) stained histology slides were retrieved and
studied. The patients’ bio-data were retrieved from the patient case
files and departmental records. After histological assessment, the
tumours were classified according to WHO recommendation. His-
tological grading and staging of adenocarcinoma was done using
the Gleason Score.
Results
Between January 1991 and December 2000, a total of 151 cases of
prostate cancer were seen, constituting 4.1% of all malignancies and
10.1% of male malignancies seen during this period. The diagnosis
was based on histopathological analysis of specimens obtained from
Trucut needle biopsies and open prostatectomies. The patients’ age
ranged from 30 to 79 years with a mean age of 64.5 years. The
peak age at diagnosis was in the seventh decade, while two rela-
tively young patients were found to have prostate cancer at the age
of 30 and 32 years, respectively. All the tumours were adenocar-
cinomas, 51.6% were poorly and 48.4% moderately differentiated
(Figs. 1 and 2).
Discussion
African-American black men are at an increased risk of developing
prostate cancer. Studies done on African-Americans in the USA for
the evaluation of prostate cancer disparities in this population have
shown that African-Americans present with a more advanced stage
of prostate cancer at diagnosis and have higher mortality rates due
to prostate cancer than whites [17–20]. According to the American
Cancer Society [21], black men have a 1-in-5 lifetime probability of
developing invasive prostate cancer compared to 1 in 7 for whites.
The lifetime probability of dying from invasive prostate cancer is
1 in 23 for black men and 1 in 38 for white men. Black men also
experience disparities relative to prostate cancer survival with an
Figure  1  Age distribution of prostate cancer in A.B.U.T.H, Zaria.
Figure  2  Distribution of the adenocarcinoma according to Gleason
Grade.
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overall 5-year survival rate of 95% for black men and 100% for
white men [21].
Although the incidence of prostate cancer was reported to be low
among Africans in the past [5–8], recent reviews across Africa have
shown that prostate cancer is now emerging as the most common
male malignancy [22].
The 151 prostate cancer cases studied in this review constituted 4.4%
of all malignancies and 10.1% of male malignancies seen in Zaria
during the period under review. This is similar to most reports from
Nigeria [23–25] and from parts of West Africa [26,27]. On the other
hand, in several other community-based cohort studies on cancer in
men, hepatocellular carcinoma is the most common male cancer
[28,29]. This disparity is due to the fact that hospital-based studies
do not give a true reflection of the real situation in the community, as
only those who can afford orthodox medicine come to the hospitals.
The age range in this study is 30–79 years with a mean age of 64.5
years; this is in accord with studies from Jos [23], Benin [25], Côte
d’Ivoire [26], Cameroon [27] and Port-Harcourt [30] and shows that
prostate cancer is mainly a disease affecting the elderly. However,
prostate cancer occurred a decade earlier in our patients as compared
to their white counterparts in Europe and America where it mainly
presents in the eighth decade [31]. Although, in a similar review by
Oluwole et al. [32] in Lokoja, Nigeria, a significant proportion of
prostate cancer was found in men in their fifth decade.
Two (1.3%) cases of relatively young patients aged 30 and 32
years with moderately differentiated adenocarcinoma were found
in this study. Their situation may be due to family history, genetic,
dietary or environmental factors and may require further research
in the African population. Similar observations were made by
Sakr et al. [33] in the age group 30–40 years, although this was
an autopsy study.
Most of the specimens analyzed in this study (57%) were obtained
from Trucut needle biopsies of the prostate, while 43% were
obtained during open prostatectomy procedures. This is similar
to two studies carried out in Port-Harcourt [30] and Ibadan [24],
Nigeria. However, in other studies performed in Jos [23], Benin
[25] and Kano [34] in Nigeria and a study carried out in Kenya [35],
the majority of specimens were obtained during prostatectomy. Inci-
dental carcinoma constituted 35.1% of the prostate cancer cases seen
in this review, which is significantly higher as compared to studies
from Jos [34] (12.3%), Benin [25] (13.5%) and Kenya [35] (11.9%).
Incidental carcinomas have been known to vary with the age of the
patient and the sectioning techniques [36]. However, the significant
number of incidental carcinomas in this study may be due to the fact
that it is a histopathological rather than a clinical analysis.
The frequency of high-grade prostatic intraepithelial neoplasia was
low in this study (47% vs. 49.1%, 59% and 82% reported in other
series [34,37,38]).
Adenocarcinoma was the most common histological type found in
this study which complies with reports from authors from other parts
of the world [17,18,20].
A predominance of poorly differentiated (51.7%) and moderately
differentiated (48.3%) tumours was found in this study. Most of
the poorly differentiated tumours showed marked lymphocytic
infiltration with comedo-necrosis and perineural invasion. Although
Milord et al. [39] established that infarcts of the ischaemic necrosis
type occur predominantly in nodular hyperplasia, it was found in
this study that they can occur in advanced prostate cancer as well.
Several other authors like Mandong [23] in Jos, Akang et al. [25] in
Benin, Magoha [35] in Kenya and Angwafo et al. [27] in Cameroon
also recorded similar findings in their series.
In the light of the current knowledge of the epidemiology of prostate
cancer, some of the factors contributing to a possible improvement
of the situation in our environment would include a clear-cut change
in life style, improved medical care leading to a prompt diagnosis
and a greater awareness of prostate cancer on the part of the patients
leading to an improved utilization of tertiary health care facilities
[34].
In conclusion, in order to be able to curtail a future increase in the
morbidity and mortality due to prostate cancer, there is a need for an
improved health education of our male population, increasing the
awareness of the potential threat of prostate cancer to men’s health.
This would require an improved health budget to meet international
standards and to ensure that this budgetary allocation gets to the
end user. The government ought to have the political will to judi-
ciously use what they have at their disposal to improve the health of
the population. The role of research, especially among indigenous
blacks, cannot be overemphasized as this will ensure that adequate
diagnostic techniques will be developed and proper individualized
patient treatment will be instituted for each patient. To achieve this,
there is a need for collaboration of health institutions in Nigeria and
international organizations for the exchange of technical expertise
and quality assurance to help improve the quality of care to our
patients.
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